Wondering whether to hire an MBA or an MD to head up global clinical development for your contract research organization (CRO)? You can always do what MDS Pharma Services did: get both—in one guy. He’s London native James Pusey, and he recently joined the King of Prussia, Pa.-based company as vice president and general manager of global development business, which manages late-stage trials. Pusey may be new to CROs, but he’s certainly no stranger to the pharma and biotech world. Before joining MDS, he was president and CEO of the Tempe, AZ-based biotech firm Orthologic. Prior to that, he served as executive vice president for neurology at Geneva, Switzerland-based biotech company Serono, now part of E. Merck. Been Around the Block Before that? Vice president of marketing and a therapeutic area leader for central nervous system, pain and infection at AstraZeneca USA. Before that? International medical advisor in Southeast Asia managing…more...